HIGH RISK FIBROSIS 4-SCORE IS PREDICTIVE OF ALL CAUSE, CARDIOVASCULAR AND LIVER-RELATED MORTALITY AMONG ADULTS NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES (US)

被引：0
|
作者：
Paik, James M. [1 ,2 ]
Younossi, Elena [1 ]
Keo, Wisna'Odom [1 ]
Allawi, Hussain [1 ]
Henry, Linda [3 ]
Younossi, Zobair M. [1 ,2 ,4 ]
机构：
[1] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[2] Inova Fairfax Med Campus, Ctr Liver Dis, Dept Med, Falls Church, VA USA
[3] Ctr Outcomes Res Liver Dis, Washington, DC USA
[4] Inova Hlth Syst, Inova Med, Falls Church, VA USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1376
引用
收藏
页码：820A / 820A
页数：1
相关论文
共 50 条
  • [21] Comparison of transient elastography and NAFLD fibrosis score in non-alcoholic fatty liver disease
    Wu, Y.
    Weltman, M.
    Eslick, G. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 100 - 100
  • [22] Non-alcoholic fatty liver disease (NAFLD) is associated with higher overall mortality and liver related mortality
    Ong, J. P.
    Pitts, A.
    Younossi, Z. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S5 - S5
  • [23] Incidence of liver-related morbidity and mortality in a population cohort of non-alcoholic fatty liver disease
    Mannisto, Ville T.
    Salomaa, Veikko
    Farkkila, Martti
    Jula, Antti
    Mannisto, Satu
    Erlund, Iris
    Sundvall, Jouko
    Lundqvist, Annamari
    Perola, Markus
    Aberg, Fredrik
    LIVER INTERNATIONAL, 2021, 41 (11) : 2590 - 2600
  • [24] Depression is associated with non-alcoholic fatty liver disease among adults in the United States
    Kim, Donghee
    Yoo, Eric R.
    Li, Andrew A.
    Tighe, Sean P.
    Cholankeril, George
    Harrison, Stephen A.
    Ahmed, Aijaz
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (05) : 590 - 598
  • [25] The Increase in Mortality Related to Chronic Liver Disease Is Explained By Non-Alcoholic Fatty Liver Disease (NAFLD)
    Paik, James
    Golabi, Pegah
    Sayiner, Mehmet
    Biswas, Rakesh
    Alqahtani, Saleh
    Venkatesan, Chapy
    Younossi, Zobair M.
    HEPATOLOGY, 2018, 68 : 453A - 453A
  • [26] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [27] A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD
    McKillen, B.
    Elangovan, H.
    Horsfall, L.
    Patel, P.
    Hayward, K.
    Clouston, A.
    Radford-Smith, D.
    Valery, P.
    Britton, L.
    Brown, N.
    Bernard, A.
    Powell, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 55 - 56
  • [28] FIBROSCAN-ASPARTATE AMINOTRANSFERASE SCORE PREDICTS RISK OF LIVER-RELATED EVENTS IN NON-ALCOHOLIC FATTY LIVER DISEASE
    Song, Michael W.
    Han, Nicole Xinrong
    Goyal, Tanvi
    Tay, Wei Xuan
    Urias, Esteban
    Wijarnpreecha, Karn
    Wong, Yu Jun
    Chen, Vincent L.
    GASTROENTEROLOGY, 2023, 164 (06) : S1235 - S1236
  • [29] Associations between dietary fat and non-alcoholic fatty liver disease (NAFLD) among us adults
    Lan, Qiu-Ye
    Chen, Feng
    Dai, Siyu
    GUT, 2023, 72 (SUPPL_1) : A169 - A170
  • [30] Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease
    Chan, Wah Kheong
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 183 - 184
12345